Che‐Yuan Wu

1.0k total citations
33 papers, 655 citations indexed

About

Che‐Yuan Wu is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Che‐Yuan Wu has authored 33 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Physiology and 11 papers in Psychiatry and Mental health. Recurrent topics in Che‐Yuan Wu's work include Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (10 papers) and Diabetes Treatment and Management (10 papers). Che‐Yuan Wu is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (10 papers) and Diabetes Treatment and Management (10 papers). Che‐Yuan Wu collaborates with scholars based in Canada, Norway and Germany. Che‐Yuan Wu's co-authors include Walter Swardfager, Krista L. Lanctôt, Nathan Herrmann, Sandra E. Black, Michael Ouk, Jodi D. Edwards, Jennifer S. Rabin, Maureen Pakosh, Bradley J. MacIntosh and Mario Masellis and has published in prestigious journals such as Neurology, Diabetes Care and Stroke.

In The Last Decade

Che‐Yuan Wu

32 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Che‐Yuan Wu Canada	15	229	188	174	173	85	33	655
Kapil Gudala India	13	429 1.9×	132 0.7×	142 0.8×	263 1.5×	166 2.0×	29	1.0k
Lindsay Zilliox United States	9	397 1.7×	123 0.7×	119 0.7×	175 1.0×	95 1.1×	14	860
Emily B. Button Canada	15	283 1.2×	166 0.9×	187 1.1×	76 0.4×	35 0.4×	23	679
Antonietta Fava Italy	16	381 1.7×	152 0.8×	147 0.8×	193 1.1×	189 2.2×	26	988
Patrick Imfeld Switzerland	8	268 1.2×	112 0.6×	158 0.9×	135 0.8×	223 2.6×	8	668
Alastair Mander Australia	7	510 2.2×	247 1.3×	254 1.5×	138 0.8×	176 2.1×	10	1.1k
Ding‐Yuan Tian China	15	474 2.1×	138 0.7×	210 1.2×	43 0.2×	96 1.1×	28	830
Mohammad Hadi Gharedaghi United States	12	93 0.4×	60 0.3×	138 0.8×	74 0.4×	78 0.9×	30	598
Michael Ouk Canada	11	133 0.6×	105 0.6×	87 0.5×	51 0.3×	54 0.6×	15	348

Countries citing papers authored by Che‐Yuan Wu

Since Specialization

Citations

This map shows the geographic impact of Che‐Yuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Che‐Yuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Che‐Yuan Wu more than expected).

Fields of papers citing papers by Che‐Yuan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Che‐Yuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Che‐Yuan Wu. The network helps show where Che‐Yuan Wu may publish in the future.

Co-authorship network of co-authors of Che‐Yuan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Che‐Yuan Wu. A scholar is included among the top collaborators of Che‐Yuan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Che‐Yuan Wu. Che‐Yuan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Che‐Yuan, Abhinav Sharma, Jodi D. Edwards, et al.. (2025). Sodium-glucose Cotransporter-2 Inhibitor Initiation and Incident Dementia in Heart Failure With Diabetes: A Population-based Cohort Study. Journal of Cardiac Failure. 1 indexed citations

Wu, Che‐Yuan, Gillian Coughlan, Tanvi A. Puri, et al.. (2024). Associations Between Age at Menopause, Vascular Risk, and 3-Year Cognitive Change in the Canadian Longitudinal Study on Aging. Neurology. 102(9). e209298–e209298. 17 indexed citations

Wu, Che‐Yuan, Baiju R. Shah, Abhinav Sharma, et al.. (2024). Timing of Sodium–Glucose Cotransporter 2 Inhibitor Initiation and Post-Discharge Outcomes in Acute Heart Failure with Diabetes: A Population-Based Cohort Study. European Journal of Heart Failure. 27(2). 307–316. 4 indexed citations

Wu, Che‐Yuan, Myuri Ruthirakuhan, Jodi D. Edwards, et al.. (2024). Latent profiles of modifiable dementia risk factors in later midlife: relationships with incident dementia, cognition, and neuroimaging outcomes. Molecular Psychiatry. 30(2). 450–460. 3 indexed citations

Cogo‐Moreira, Hugo, Che‐Yuan Wu, Krista L. Lanctôt, et al.. (2023). State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 9(1). e12376–e12376. 10 indexed citations

Wu, Che‐Yuan, et al.. (2023). Association between G‐Protein Coupled Receptor 55 (GPR55) Single Nucleotide Polymorphisms and Alzheimer’s Disease. Alzheimer s & Dementia. 19(S15). 2 indexed citations

Wu, Che‐Yuan, Baiju R. Shah, Jodi D. Edwards, et al.. (2023). Association of sulfonylureas with the risk of dementia: A population‐based cohort study. Journal of the American Geriatrics Society. 71(10). 3059–3070. 20 indexed citations

Wu, Che‐Yuan, Refik Saskin, Baiju R. Shah, et al.. (2023). No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes. Journal of Internal Medicine. 295(1). 68–78. 11 indexed citations

Wu, Che‐Yuan, Michael Ouk, Bradley J. MacIntosh, et al.. (2022). Glucose-lowering drugs, cognition, and dementia: The clinical evidence. Neuroscience & Biobehavioral Reviews. 137. 104654–104654. 10 indexed citations

10.

Wu, Che‐Yuan, Di Yu, Esther Kim, et al.. (2022). Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis. Parkinsonism & Related Disorders. 101. 119–128. 26 indexed citations

11.

Wu, Che‐Yuan, Baiju R. Shah, Jodi D. Edwards, et al.. (2022). Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study. Diabetes Care. 46(2). 297–304. 86 indexed citations

12.

Perlman, George, Hugo Cogo‐Moreira, Che‐Yuan Wu, Nathan Herrmann, & Walter Swardfager. (2022). Depression interacts with allostatic load to predict cognitive decline in middle age. Psychoneuroendocrinology. 146. 105922–105922. 8 indexed citations

13.

Marzolini, Susan, et al.. (2021). Associations Between Time After Stroke and Exercise Training Outcomes: A Meta‐Regression Analysis. Journal of the American Heart Association. 10(24). e022588–e022588. 10 indexed citations

14.

Ouk, Michael, Che‐Yuan Wu, Jennifer S. Rabin, et al.. (2021). Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia. Alzheimer s Research & Therapy. 13(1). 147–147. 16 indexed citations

15.

Chan, Brian, Che‐Yuan Wu, Michelle Nguyen, et al.. (2021). Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis. Brain Behavior and Immunity. 100. 55–69. 47 indexed citations

16.

Wu, Che‐Yuan, Michael Ouk, Di Yu, et al.. (2020). Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid. Ageing Research Reviews. 62. 101130–101130. 40 indexed citations

17.

Ouk, Michael, Che‐Yuan Wu, Jennifer S. Rabin, et al.. (2020). Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. Neurobiology of Aging. 100. 22–31. 24 indexed citations

18.

Herrmann, Nathan, Hugo Cogo‐Moreira, Michael Ouk, et al.. (2020). A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease. Journal of Neuroinflammation. 17(1). 84–84. 50 indexed citations

19.

Wu, Che‐Yuan, Michael Ouk, Jodi D. Edwards, et al.. (2020). Relationships between oral hypoglycemic drugs and memory decline in people with type 2 diabetes: A stratified longitudinal observational study. Alzheimer s & Dementia. 16(S6). 1 indexed citations

20.

Wu, Che‐Yuan, et al.. (2019). The complement cascade in Alzheimer’s disease: a systematic review and meta-analysis. Molecular Psychiatry. 26(10). 5532–5541. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact